Search Results 281-290 of 7788 for SC

  1. Get Started - Mayo Clinic

    This content does not have an Arabic version. Skip to content. Mayo ... SC: Mayo Clinic Breadcrumb. Home · Complex Care Program. Sections Complex Care ...

  2. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    ... [SC]), and an immunomodulator (oral methotrexate) on endoscopic remission in participants with newly-diagnosed Crohn's Disease (CD) stratified at higher risk ...

  3. Nonalcoholic Steatohepatitis Clinical Trials

    ... (sc) to adult subjects with suspected or confirmed diagnosis of noncirrhotic nonalcoholic steatohepatitis (NASH) with no fibrosis to moderate fibrosis ...

  4. Rectal Adenocarcinoma Clinical Trials

    This is a multicenter, open-label, Phase 1 study in participants with colorectal cancer (CRC) or gastric cancer to study the safety and tolerability of SC ...

  5. Irritable Bowel Syndrome Clinical Trials - Mayo Clinic Research

    The purpose of this study is to obtain long term safety and tolerability data of vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative ...

  6. Nonalcoholic Steatohepatitis Clinical Trials

    ... (sc) to adult subjects with suspected or confirmed diagnosis of noncirrhotic nonalcoholic steatohepatitis (NASH) with no fibrosis to moderate fibrosis ...

  7. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    About this study. The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks ...

  8. Seizures - Diagnosis and treatment - Mayo Clinic

    Schachter SC. Evaluation and management of the first seizure in adults. https://www.uptodate.com/contents/search. Accessed July 31, 2024. AskMayoExpert ...

  9. Publications - Cheryl L. Willman, M.D. - Mayo Clinic

    ... SC, Gastier-Foster JM, Harvey R, Chen IM, Roberts KG, Mullighan CG, Willman C, Winick N, Carroll WL, Rau RE, Teachey DT, Hunger SP, Raetz EA, Devidas M ...

  10. Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Patients With PL - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of daily subcutaneous (SC) metreleptin treatment in subjects with familial partial lipodystrophy ( ...